Pricing Log in Create free account
Friday 6 November 2026 Export HLN’s income statement to Excel — free account

Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%
Market cap
$40.2B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
2.16%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
63/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Haleon PLC Sponsored ADR (HLN) Net income

Alert me on Net income

Haleon PLC Sponsored ADR's net income for fiscal 2025 was $2.2B, up 17.5% from $1.9B in fiscal 2024. Over the twelve months to 30 June 2026 it was $3.1B. Over the past ten years it has ranged from $0.00 (fiscal 2021) to $2.2B (fiscal 2025) — the current reading is the highest in ten years. Haleon PLC Sponsored ADR ranks 2nd of 84 Drug Manufacturers Specialty & Generic companies by net income.

Net income, annual

Embed this chart

Annual newest first

Period Net income Change
FY2025 $2.2B 17.53%
FY2024 $1.9B 36.39%
FY2023 $1.4B (0.15%)
FY2022 $1.4B —
FY2021 $0.00 —
FY2020 $1.6B 81.99%
FY2019 $861.8M —

Against its own ten years

Low $0.00 High $2.2B
Ten-year median $1.4B
Current reading's percentile 100

Net income against peers

Company Net income
TAK Takeda Pharmaceutical Co. compare $3.2B
HLN Haleon PLC Sponsored ADR $3.1B
ZTS Zoetis Inc. compare $2.6B
UTHR United Therapeutics Corporation compare $1.2B
NBIX Neurocrine Biosciences, Inc. compare $702.5M
TEVA Teva Pharmaceutical Industries Ltd. compare $508.0M
RDY Dr. Reddy's Laboratories Ltd compare $273.0M
ELAN Elanco Animal Health Incorporated compare −$199.0M
VTRS Viatris Inc. compare −$607.8M

What Net income is

Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.

Reported line item

The full definition of Net income →

More on HLN